Sat, Dec 20, 2014, 2:10 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

MELA Sciences, Inc. Message Board

  • dwoods4q dwoods4q Jan 4, 2012 12:28 PM Flag

    Insurance Reimbursement

    Has anybody seen any info from company on how Doctors/users of device will be paid by insurance companies? Will the insurance companies cover usageage and at what rates? More or less than a byopsy etc etc.....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • First and foremost it is not a biopsy replacement and could in fact result in more biopsies for some dermatologists. So it will not be cutting into their biopsy revenue so to speak.

      As far as reimbursement. It takes a minimum of 18 months and more often 2 years plus if the company pursues it aggressively. MELA has said they plan to take their time with the goal of building the case for MelaFind as a cost saver because it is FAR cheaper to treat Melanoma in the early stages. They hope to get a higher reimbursement by getting the cost saving data in order before pursuing reimbursement. In other words they are looking for a higher reimbursement rather than a fast one which would presumably be at a lower rate. Their plan in the short term (1 to 3 years) is to reply on self pay. The have said that US Derms have a well established self-pay business model. (Think Botox).

      Listen to some of the recent CC. MELA CEO Gulfo talked about this issue in depth on one of the recent investor conference calls.

 
MELA
1.30-0.0100(-0.76%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST